Tags

Type your tag names separated by a space and hit enter

Enantioselective beta-lactone formation from ketene and aldehydes catalyzed by a chiral oxazaborolidine.
Org Lett. 2006 Oct 12; 8(21):4943-5.OL

Abstract

[reaction: see text] A novel catalytic system has been developed for the enantioselective synthesis of beta-lactones from ketene and aldehydes.

Authors+Show Affiliations

Department of Chemistry and Chemical Biology, Harvard University, 12 Oxford Street, Cambridge, Massachusetts 02138, USA.No affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

17020342

Citation

Gnanadesikan, Vijay, and E J. Corey. "Enantioselective Beta-lactone Formation From Ketene and Aldehydes Catalyzed By a Chiral Oxazaborolidine." Organic Letters, vol. 8, no. 21, 2006, pp. 4943-5.
Gnanadesikan V, Corey EJ. Enantioselective beta-lactone formation from ketene and aldehydes catalyzed by a chiral oxazaborolidine. Org Lett. 2006;8(21):4943-5.
Gnanadesikan, V., & Corey, E. J. (2006). Enantioselective beta-lactone formation from ketene and aldehydes catalyzed by a chiral oxazaborolidine. Organic Letters, 8(21), 4943-5.
Gnanadesikan V, Corey EJ. Enantioselective Beta-lactone Formation From Ketene and Aldehydes Catalyzed By a Chiral Oxazaborolidine. Org Lett. 2006 Oct 12;8(21):4943-5. PubMed PMID: 17020342.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Enantioselective beta-lactone formation from ketene and aldehydes catalyzed by a chiral oxazaborolidine. AU - Gnanadesikan,Vijay, AU - Corey,E J, PY - 2006/10/6/pubmed PY - 2007/6/28/medline PY - 2006/10/6/entrez SP - 4943 EP - 5 JF - Organic letters JO - Org Lett VL - 8 IS - 21 N2 - [reaction: see text] A novel catalytic system has been developed for the enantioselective synthesis of beta-lactones from ketene and aldehydes. SN - 1523-7060 UR - https://www.unboundmedicine.com/medline/citation/17020342/Enantioselective_beta_lactone_formation_from_ketene_and_aldehydes_catalyzed_by_a_chiral_oxazaborolidine_ L2 - https://doi.org/10.1021/ol061979h DB - PRIME DP - Unbound Medicine ER -